Venus Remedies Ltd.
VENUSREM Share PricePharmaceuticals & Drugs
₹464.55
5.2 (1.1%)
As on September 8, 2025
Exchange Scrips: BSE526953NSEVENUSREMISININE411B01019
Market Cap ₹ 619 Cr
P/E Ratio 13.7
Dividend Yield N/A
Performance
Market performance
Open453.05
High467.9
Volumes16,998
Prev464.55
Low450.2
As on2025-09-08
Historical performance
1 Year High567.8
3 Year High567.8
5 Year High639
1 Year Low270.25
3 Year Low145.8
5 Year Low96.1
Fundamentals
Company Valuation
Market Cap (₹Cr)
619
Face Value (₹)
10
P/E Ratio
13.7
Dividend Yield
N/A
Investment Returns
1 Year
29.3%
3 Years
115.2%
5 Years
361.3%
10 Years
307.1%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 463.72 | Bullish |
| 10-DMA | 466.23 | Bearish |
| 20-DMA | 476.02 | Bearish |
| 50-DMA | 487.79 | Bearish |
| 100-DMA | 431.99 | Bullish |
| 200-DMA | 369.57 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 5 | 5 | 5 | 5 | 5 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 5 | 5 | 5 | 5 | 5 |
| Public Investors | 19302 | 19977 | 19766 | 19552 | 19609 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 13.7.
- 3Y Stock Price CAGR of the stock is 29.7.
- The stock has a beta of 1.0.
- In the last financial year, the company had an EBITDA of ₹845 Million.
- The company generated revenue of ₹6479 Million in the previous financial year.
Venus Remedies Ltd.
464.555.2 (1.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1301442.8
No. of Shares: 2802 (Approx)
Performance:30.1%
P/L: ₹301442.8
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent